State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
Open-end / ETFRegistrant
SPDR SERIES TRUST
Class ticker
Net Assets
$428,431,440
Holdings
67
Latest Report
Jun 30, 2026
Net Assets Over Time
Holdings · 67
Export CSV
Showing 1–50
of 67 holdings by value
· page 1 of 2
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
|
State Street Global Advisors
|
857492706 | 36,754,275 | $36,754,275 | 8.58% | Long | STIV | |
| Definium Therapeutics Inc | DFTX | 281,317 | $13,233,152 | 3.09% | Long | EC | |
| MBX Biosciences Inc | MBX | 210,962 | $11,645,102 | 2.72% | Long | EC | |
| Alumis Inc | ALMS | 325,914 | $9,171,220 | 2.14% | Long | EC | |
| AtaiBeckley Inc | ATAI | 1,729,574 | $9,114,855 | 2.13% | Long | EC | |
| Trevi Therapeutics Inc | TRVI | 487,893 | $9,099,204 | 2.12% | Long | EC | |
| Enliven Therapeutics Inc | ELVN | 176,696 | $8,967,322 | 2.09% | Long | EC | |
| Amylyx Pharmaceuticals Inc | AMLX | 485,721 | $8,723,549 | 2.04% | Long | EC | |
| VeraDermics Inc | MANE | 70,310 | $8,643,911 | 2.02% | Long | EC | |
| Ligand Pharmaceuticals Inc | LGND | 26,334 | $8,323,914 | 1.94% | Long | EC | |
| Nuvation Bio Inc | NUVB | 1,427,463 | $8,107,990 | 1.89% | Long | EC | |
| Edgewise Therapeutics Inc | EWTX | 198,593 | $8,068,834 | 1.88% | Long | EC | |
| Nektar Therapeutics | NKTR | 115,142 | $8,038,063 | 1.88% | Long | EC | |
| Liquidia Corp | LQDA | 100,195 | $7,988,547 | 1.86% | Long | EC | |
| Maze Therapeutics Inc | MAZE | 265,830 | $7,932,367 | 1.85% | Long | EC | |
| Harrow Inc | HROW | 182,110 | $7,734,212 | 1.81% | Long | EC | |
| EyePoint Inc | EYPT | 530,232 | $7,582,318 | 1.77% | Long | EC | |
| Amneal Pharmaceuticals Inc | AMRX | 426,750 | $7,387,043 | 1.72% | Long | EC | |
| Ocular Therapeutix Inc | OCUL | 748,033 | $7,345,684 | 1.71% | Long | EC | |
| Corcept Therapeutics Inc | CORT | 83,688 | $7,276,672 | 1.70% | Long | EC | |
|
Crinetics Pharmaceuticals Inc
|
22663K107 | 190,494 | $7,128,285 | 1.66% | Long | EC | |
| Pacira BioSciences Inc | PCRX | 279,152 | $7,082,086 | 1.65% | Long | EC | |
| Merck & Co Inc | MRK | 54,900 | $7,054,650 | 1.65% | Long | EC | |
| Indivior Pharmaceuticals Inc | INDV | 171,638 | $7,042,307 | 1.64% | Long | EC | |
| Elanco Animal Health Inc | ELAN | 285,865 | $7,035,138 | 1.64% | Long | EC | |
| Johnson & Johnson | JNJ | 27,417 | $6,963,095 | 1.63% | Long | EC | |
| Eli Lilly & Co | LLY | 5,757 | $6,905,119 | 1.61% | Long | EC | |
|
Jazz Pharmaceuticals PLC
|
000000000 | 28,473 | $6,861,139 | 1.60% | Long | EC | |
| Collegium Pharmaceutical Inc | COLL | 187,866 | $6,800,749 | 1.59% | Long | EC | |
| Bristol-Myers Squibb Co | BMY | 117,586 | $6,775,305 | 1.58% | Long | EC | |
| Supernus Pharmaceuticals Inc | SUPN | 144,999 | $6,743,903 | 1.57% | Long | EC | |
|
Royalty Pharma PLC
|
000000000 | 119,915 | $6,723,634 | 1.57% | Long | EC | |
| Tarsus Pharmaceuticals Inc | TARS | 106,709 | $6,716,264 | 1.57% | Long | EC | |
|
WaVe Life Sciences Ltd
|
000000000 | 1,155,091 | $6,711,079 | 1.57% | Long | EC | |
| Harmony Biosciences Holdings Inc | HRMY | 184,265 | $6,709,089 | 1.57% | Long | EC | |
| Organon & Co | OGN | 488,626 | $6,615,996 | 1.54% | Long | EC | |
| ANI Pharmaceuticals Inc | ANIP | 79,881 | $6,612,549 | 1.54% | Long | EC | |
| Viatris Inc | VTRS | 414,570 | $6,583,372 | 1.54% | Long | EC | |
|
Esperion Therapeutics Inc
|
29664W105 | 2,082,103 | $6,579,445 | 1.54% | Long | EC | |
| Axsome Therapeutics Inc | AXSM | 26,541 | $6,496,441 | 1.52% | Long | EC | |
| Innoviva Inc | INVA | 284,255 | $6,455,431 | 1.51% | Long | EC | |
| BioAge Labs Inc | BIOA | 262,153 | $6,425,370 | 1.50% | Long | EC | |
| Prestige Consumer Healthcare Inc | PBH | 133,070 | $6,290,219 | 1.47% | Long | EC | |
| Rapport Therapeutics Inc | RAPP | 147,854 | $6,161,076 | 1.44% | Long | EC | |
| Pfizer Inc | PFE | 255,385 | $6,149,671 | 1.44% | Long | EC | |
| Omeros Corp | OMER | 640,960 | $6,095,530 | 1.42% | Long | EC | |
|
Perrigo Co PLC
|
000000000 | 585,303 | $6,081,298 | 1.42% | Long | EC | |
| Xeris Biopharma Holdings Inc | XERS | 753,307 | $5,966,191 | 1.39% | Long | EC | |
| Zoetis Inc | ZTS | 80,428 | $5,779,556 | 1.35% | Long | EC | |
| Eton Pharmaceuticals Inc | ETON | 154,434 | $5,590,511 | 1.30% | Long | EC |